Can a new generation of chromatography techniques and technologies get things moving again?

The days of “low-hanging fruit” in drug discovery are a thing of the past.

How to use a knowledge repository that doesn’t retire or leave you for a competitor.

Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right?

The launch of the world’s first biosimilar monoclonal antibody was a big step forward from a regulatory and scientific standpoint.

Could medicines be made more effective with better timing?

Will FDA fast review and voucher incentives make a difference?

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

The 2014 Access to Medicine index shows progress – but companies remain “conservative”